Risedronate Sodium

2 trials 1 recruiting MMusculoskeletal

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

5 Countries

Phase II

Phase IV

Phase II: 1 Phase IV: 1

Indications tested

Dilated cardiomyopathy 1

Sponsors using this IMP

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia 1 NHS Lothian 1 University Of Edinburgh 1

All trials

2 total

Treatment with Risedronate for dilated cardiomyopathy due to Troponin T alteration due to K210 deletion. Recruiting

2023-509431-29-00 Phase II 1 country Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid Ended

2024-519705-36-00 Phase IV 4 countries NHS Lothian; University Of Edinburgh

Showing 1–2 of 2 trials

← All drugs A–Z